APPOINTMENT OF A NEW CHIEF EXECUTIVE OFFICER

Longjumeau, March 14, 2019

The PCAS Board of Directors met on March 14, 2019, and decided to remove Mr. Vincent Touraille from his position as CEO of PCAS.

To deal with the challenges currently facing PCAS Group, the Board of Directors has selected Mr. Frédéric Desdouits as his replacement. Previously, Mr. Desdouits held the position of PCAS Deputy CEO and headed up the CDMO Business Unit.

The Board of Directors would like to warmly thank Mr. Vincent Touraille for heading PCAS since 2010 and supporting the strong development of the group.

Mr. Pierre Luzeau will continue on as Chairman of the Board of Directors.

ABOUT PCAS 

PCAS specializes in the development and production of complex molecules for life sciences and innovative technologies. With 7% of its net sales earmarked for R&D and a large international footprint, PCAS is the preferred industrial partner for market-leading major global groups. Boasting especially high standards, the company offers a growing range of proprietary products and solutions in leading-edge segments. PCAS generated net sales of €206.7 million in 2018 and employs close to 1 100 people in six countries.

To find out more about PCAS, visit: www.pcas.com

PCASNewcap
Frédéric Desdouits / Eric Moissenot
PCAS		Emmanuel Huynh / Louis-Victor Delouvrier
NewCap
Financial communication and Investor Relations
Tel. : +33 1 69 79 61 32
www.pcas.com		Tel. : +33 1 44 71 98 53
pcas@newcap.eu


Attachment

  • PCAS - March 14, 2019 DEF